Epiq Capital Group, LLC is > 10% Shareholder of Lucira Health, Inc.. Currently has a direct ownership of 32,176 shares of LHDX, which is worth approximately $965. The most recent transaction as insider was on Dec 14, 2022, when has been sold 13,124,349 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 32.2K
0% 3M change
0% 12M change
Total Value Held $965

EPIQ Capital Group, LLC Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 14 2022
SELL
Other acquisition or disposition
-
13,124,349 Reduced 99.76%
32,176 Common Stock
Feb 05 2021
BUY
Open market or private purchase
$58,849,988 $17.0 p/Share
3,461,764 Added 50.0%
3,461,764 Common Stock
Feb 05 2021
BUY
Conversion of derivative security
$164,810,937 $17.0 p/Share
9,694,761 Added 92.95%
735,475 Common Stock

Also insider at

CRTX
Cortexyme, Inc. Healthcare
AMTI
Applied Molecular Transport Inc. Healthcare
ECG

Epiq Capital Group, LLC

> 10% Shareholder
San Francisco, CA

Track Institutional and Insider Activities on LHDX

Follow Lucira Health, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LHDX shares.

Notify only if

Insider Trading

Get notified when an Lucira Health, Inc. insider buys or sells LHDX shares.

Notify only if

News

Receive news related to Lucira Health, Inc.

Track Activities on LHDX